Learn More
Nitroimidazoles such as PA-824 and OPC-67683 are currently in clinical development as members of a promising new class of therapeutics for tuberculosis. While the antitubercular activity of these(More)
Gallium complexes containing bridging phenyl groups were prepared and characterized. Treatment of triphenylgallium with 3,5-dimethylpyrazole, 3,5-diphenylpyrazole, or 3,5-di-tert-butylpyrazole in a(More)